Linomide inhibits insulitis and modulates cytokine production in pancreatic islets in the nonobese diabetic mouse-Reference-Cited by-同舟云学术

Linomide inhibits insulitis and modulates cytokine production in pancreatic islets in the nonobese diabetic mouse

Published:2003-01 Issue:1 Volume:3 Page:17-30
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Dahlén Eva,Dawe Kim,Ohlsson Lennart,Hall Håkan,Hedse Karin,Annersten Karin,Åström Mikael,Gross David J,Hedlund Gunnar

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference65 articles.

1. Breeding of a nonobese, diabetic strain of mice;Makino;Exp. Anim.,1980

2. Immunohistochemical analyses of pancreatic macrophages and CD4 and CD8 T cell subsets prior to and following diabetes in the NOD mouse;Reddy;Pancreas,1995

3. Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic nonobese diabetic [NOD] mice: a longitudinal study;Miyazaki;Clin. Exp. Immunol.,1985

4. Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse;Dahlen;J. Immunol.,1998

5. Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice;Koike;Diabetes,1987

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CuBr2-Catalyzed Three-Component Coupling for Synthesis of Quinoline-2,4-dicarboxyl Derivatives;Chinese Journal of Organic Chemistry;2014

2. Inhibitory effect of linomide on lipopolysaccharide-induced proinflammatory cytokine tumor necrosis factor-alpha production in RAW264.7 macrophages through suppression of NF-κB, p38, and JNK activation;Immunology Letters;2007-12

3. Roquinimex-mediated protection effect on the development of chronic graft-versus-host disease in mice is associated with induction of Th1 cytokine production and inhibition of proinflammatory cytokine production;Life Sciences;2007-10

4. Design, synthesis, and biological evaluation of novel 4-hydro-quinoline-3-carboxamide derivatives as an immunomodulator;Bioorganic & Medicinal Chemistry Letters;2005-06